A phase I study of an angiogenesis inhibitor, TNP-470 (AGM-1470), administered to patients with HIV-associated Kaposi's sarcoma
収録刊行物
-
- Proc. Am. Soc. Clin. Oncol.
-
Proc. Am. Soc. Clin. Oncol. 13 51-, 1994